Centrosomal AKAP350 modulates the G1/S transition.

Stella M Mattaloni, Anabela C Ferretti, Facundo M Tonucci, Cristián Favre, James R Goldenring, M Cecilia Larocca
{"title":"Centrosomal AKAP350 modulates the G<sub>1</sub>/S transition.","authors":"Stella M Mattaloni,&nbsp;Anabela C Ferretti,&nbsp;Facundo M Tonucci,&nbsp;Cristián Favre,&nbsp;James R Goldenring,&nbsp;M Cecilia Larocca","doi":"10.4161/cl.26331","DOIUrl":null,"url":null,"abstract":"<p><p>AKAP350 (AKAP450/AKAP9/CG-NAP) is an A-kinase anchoring protein, which recruits multiple signaling proteins to the Golgi apparatus and the centrosomes. Several proteins recruited to the centrosomes by this scaffold participate in the regulation of the cell cycle. Previous studies indicated that AKAP350 participates in centrosome duplication. In the present study we specifically assessed the role of AKAP350 in the progression of the cell cycle. Our results showed that interference with AKAP350 expression inhibits G<sub>1</sub>/S transition, decreasing the initiation of both DNA synthesis and centrosome duplication. We identified an AKAP350 carboxyl-terminal domain (AKAP350CTD), which contained the centrosomal targeting domain of AKAP350 and induced the initiation of DNA synthesis. Nevertheless, AKAP350CTD expression did not induce centrosomal duplication. AKAP350CTD partially delocalized endogenous AKAP350 from the centrosomes, but increased the centrosomal levels of the cyclin-dependent kinase 2 (Cdk2). Accordingly, the expression of this AKAP350 domain increased the endogenous phosphorylation of nucleophosmin by Cdk2, which occurs at the G<sub>1</sub>/S transition and is a marker of the centrosomal activity of the cyclin E-Cdk2 complex. Cdk2 recruitment to the centrosomes is a necessary event for the development of the G<sub>1</sub>/S transition. Altogether, our results indicate that AKAP350 facilitates the initiation of DNA synthesis by scaffolding Cdk2 to the centrosomes, and enabling its specific activity at this organelle. Although this mechanism could also be involved in AKAP350-dependent modulation of centrosomal duplication, it is not sufficient to account for this process.</p>","PeriodicalId":72547,"journal":{"name":"Cellular logistics","volume":"3 1","pages":"e26331"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/cl.26331","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular logistics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4161/cl.26331","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

AKAP350 (AKAP450/AKAP9/CG-NAP) is an A-kinase anchoring protein, which recruits multiple signaling proteins to the Golgi apparatus and the centrosomes. Several proteins recruited to the centrosomes by this scaffold participate in the regulation of the cell cycle. Previous studies indicated that AKAP350 participates in centrosome duplication. In the present study we specifically assessed the role of AKAP350 in the progression of the cell cycle. Our results showed that interference with AKAP350 expression inhibits G1/S transition, decreasing the initiation of both DNA synthesis and centrosome duplication. We identified an AKAP350 carboxyl-terminal domain (AKAP350CTD), which contained the centrosomal targeting domain of AKAP350 and induced the initiation of DNA synthesis. Nevertheless, AKAP350CTD expression did not induce centrosomal duplication. AKAP350CTD partially delocalized endogenous AKAP350 from the centrosomes, but increased the centrosomal levels of the cyclin-dependent kinase 2 (Cdk2). Accordingly, the expression of this AKAP350 domain increased the endogenous phosphorylation of nucleophosmin by Cdk2, which occurs at the G1/S transition and is a marker of the centrosomal activity of the cyclin E-Cdk2 complex. Cdk2 recruitment to the centrosomes is a necessary event for the development of the G1/S transition. Altogether, our results indicate that AKAP350 facilitates the initiation of DNA synthesis by scaffolding Cdk2 to the centrosomes, and enabling its specific activity at this organelle. Although this mechanism could also be involved in AKAP350-dependent modulation of centrosomal duplication, it is not sufficient to account for this process.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中心体AKAP350调节G1/S转变。
AKAP350 (AKAP450/AKAP9/CG-NAP)是一种a激酶锚定蛋白,可向高尔基体和中心体募集多种信号蛋白。一些蛋白质通过这个支架聚集到中心体参与细胞周期的调节。先前的研究表明,AKAP350参与中心体复制。在本研究中,我们专门评估了AKAP350在细胞周期进程中的作用。我们的研究结果表明,干扰AKAP350表达抑制G1/S转变,减少DNA合成和中心体复制的起始。我们发现了一个AKAP350羧基末端结构域(AKAP350CTD),它包含AKAP350的中心体靶向结构域,并诱导DNA合成的起始。然而,AKAP350CTD的表达并未诱导中心体重复。AKAP350CTD使内源性AKAP350从中心体部分脱位,但增加了中心体细胞周期蛋白依赖性激酶2 (Cdk2)的水平。因此,AKAP350结构域的表达增加了Cdk2对核磷蛋白的内源性磷酸化,这种磷酸化发生在G1/S过渡阶段,是细胞周期蛋白E-Cdk2复合物中心体活性的标志。Cdk2向中心体募集是G1/S转变发展的必要事件。总之,我们的研究结果表明,AKAP350通过将Cdk2脚手架到中心体上,促进了DNA合成的起始,并使其在该细胞器上具有特异性活性。虽然这一机制也可能涉及akap350依赖性中心体复制的调节,但不足以解释这一过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Vps34 and the Armus/TBC-2 Rab GAPs: Putting the brakes on the endosomal Rab5 and Rab7 GTPases. Integrative biological simulation praxis: Considerations from physics, philosophy, and data/model curation practices. Agents and networks to model the dynamic interactions of intracellular transport. How can biological modeling help cell biology? Amino acid and small GTPase regulation of mTORC1.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1